An assessment was made of the relative contributions of a spontaneous mutation to rifampin resistance and a cryptic plasmid, pTA2, to competitive nodulation of Medicago saliva by a strain of Rhizobium meliloti. This was facilitated by use of rifampin-resistant derivatives of this strain in which pTA2 was originally present, cured, or reintroduced. Both curing of pTA2 and spontaneous mutation to rifampin resistance significantly influenced nodulating competitiveness, but the effect of rifampin resistance was greater and such that the contribution of pTA2 was evident only in cases in which paired competitors had the common rifampin resistance background. The data suggest that rifampin-resistant derivatives contain an altered RNA polymerase insensitive to the action of rifampin. All R. melhoti derivatives had symbiotic characteristics and phage susceptibility patterns similar to those of the wild type. Plasmid pTA2 transfer or other genetic interchange was not detected in nodules of M. saliva inoculated with paired competitors.Legume inoculation in soils containing indigenous Rhizobium populations frequently results in only small proportions of nodules produced by introduced strains (27, 33). Therefore, the improvement of nodulating competitiveness in Rhizobium strains intended for legume inoculation is of considerable practical importance.It has been reported that the symbiotic plasmid in R. leguminosarum (5), antibiotic resistance in R. trifolii (8), and genetic factors in the legume host (10, 17) influence competitive success in nodulation. However, the genetic basis of nodulating competitiveness in Rhizobium spp. is still not understood. Bromfield (6) reported that a derivative of a strain of R. meliloti obtained by spontanteous mutation to rifampin resistance and cured of a 135-megadalton cryptic plasmid (pTA2) was significantly less competitive in nodulation than the wild type. The main objective of this investigation was to assess the relative contributions of spontaneous mutation to rifampin resistance and plasmid pTA2 to competitive nodulation by this strain of R. meliloti. This was facilitated by use of rifampin-resistant derivatives with pTA2 originally present, eliminated, or reintroduced. MATERIALS AND METHODS R. meliloti and medium. The R. meliloti strains used in this investigation are described in Table 1. All R. meliloti were characterized by the procedure of Lesley (20) with the same 16 distinct phages. R. meliloti IZ450(pTA2) and derivatives were grown on yeast extract-mannitol agar (YEM) modified from Fred et al. (16) by using 1 g of yeast extract (Difco Laboratories) per liter and omitting CaCO3. Competition experiment. Competition for nodulation between R. meliloti IZ450(pTA2) and derivatives was examined with Medicago sativa cv. Apollo grown in modified Leonard jars (32) containing quartz sand and supplied with nitrogen-free nutrient solution (22). Seedlings from surfacesterilized seed (32) were planted and inoculated with 1 ml of cell suspension washed from the surface of a YEM slope in * Cor...